These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 8874388

  • 1. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, Greiner TC.
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [Abstract] [Full Text] [Related]

  • 2. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
    Liu JR, Lin Q, Wu XY.
    Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
    [Abstract] [Full Text] [Related]

  • 3. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP.
    Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055
    [Abstract] [Full Text] [Related]

  • 4. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.
    Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF.
    Oncogene; 1995 Feb 02; 10(3):523-8. PubMed ID: 7845677
    [Abstract] [Full Text] [Related]

  • 5. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P, De Matteo E, Merediz A, Preciado MV.
    Arch Virol; 2004 Aug 02; 149(8):1515-26. PubMed ID: 15290377
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.
    Ai Zheng; 2006 Feb 02; 25(2):136-42. PubMed ID: 16480574
    [Abstract] [Full Text] [Related]

  • 7. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsui S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM.
    Am J Pathol; 1998 Jan 02; 152(1):191-8. PubMed ID: 9422536
    [Abstract] [Full Text] [Related]

  • 8. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF.
    Hum Pathol; 2001 Sep 02; 32(9):963-9. PubMed ID: 11567226
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG, Nador RG, Cesarman E, Chadburn A, Knowles DM.
    Am J Pathol; 1997 Sep 02; 151(3):805-12. PubMed ID: 9284829
    [Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb 02; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA, Zekri AR, Asaad N, El-Houssini S, Khalid HM, Sedky LM, Mokhtar NM.
    Histopathology; 2006 Apr 02; 48(5):516-28. PubMed ID: 16623777
    [Abstract] [Full Text] [Related]

  • 12. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA, Jauregui MP, Hsi ED, Novoa-Takara L, Chang CC.
    Hum Pathol; 2006 Sep 02; 37(9):1130-6. PubMed ID: 16938517
    [Abstract] [Full Text] [Related]

  • 13. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
    Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, Krenacs L, Kingma DW, Raffeld M, Jaffe ES.
    Mod Pathol; 1998 Aug 10; 11(8):754-61. PubMed ID: 9720504
    [Abstract] [Full Text] [Related]

  • 15. [Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: prevalence of the LMP1 oncogene deletions and A and B viruses strains].
    Trimeche M, Korbi S, Ziadi S, Amara K, Boniver J, de Leval L.
    Ann Biol Clin (Paris); 2005 Aug 10; 63(2):193-9. PubMed ID: 15771977
    [Abstract] [Full Text] [Related]

  • 16. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
    Guiretti DM, Chabay PA, Valva P, Stefanoff CG, Barros MH, De Matteo E, Renault IZ, Preciado MV, Hassan R.
    J Med Virol; 2007 Nov 10; 79(11):1730-22. PubMed ID: 17854036
    [Abstract] [Full Text] [Related]

  • 17. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L, Lome-Maldonado C, Schwarzmann F, Gredler E, Reyes E, Angeles-Angeles A, Fend F.
    Mod Pathol; 1998 Feb 10; 11(2):200-8. PubMed ID: 9504692
    [Abstract] [Full Text] [Related]

  • 18. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S.
    Mod Pathol; 2003 Jun 10; 16(6):566-73. PubMed ID: 12808062
    [Abstract] [Full Text] [Related]

  • 19. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE.
    Mod Pathol; 1996 Jun 10; 9(6):621-30. PubMed ID: 8782198
    [Abstract] [Full Text] [Related]

  • 20. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H, McQuain C, Martin J, Rothenberger S, Drexler HG, Berger C, Bachmann E, Kittler EL, Odermatt BF, Quesenberry PJ.
    Oncogene; 1996 Sep 05; 13(5):947-53. PubMed ID: 8806684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.